LONDON and NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, ...

Compass Diversified (NYSE: CODI) announced it will release its financial results for the fourth quarter and full year ending December 31, 2024, on February 27, 2025, after market close. A conference ...

Joe Fricke with Compass Financial stops by to tell us the different phases of retirement planning. Are you ready to take your ...

WESTPORT, Conn., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market businesses, announced today its consolidated operating ...

Are you ready to take your first steps towards financial freedom? Whether you need help with financial planning, tax ...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today ...

Compass has resolved the significant issues with its financial filings, known as material weaknesses, meeting a self-imposed deadline. The disclosure generally refers to a systemic problem at a ...

In the ongoing Phase 2/3 study of tovecimig (DLL4 x VEGF-A bispecific antibody) in patients with advanced biliary tract cancer, fewer deaths have been observed than originally projected. We believe ...

CODI emphasizes that the investigation is solely focused on its subsidiary Lugano, reassuring investors about the stability and performance of its other eight subsidiaries. The company maintains ...

Financial Compass Group, LLC is commemorating 20 years of serving business owners, individuals, and families with a thoughtful, planning-centered approach to financial decision-making. Since its ...

Richard Shakter, a founding partner of Financial Compass Group, LLC, is a seasoned financial advisor with 35 years of ...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in mental health, today ...